Methods for predicting methotrexate polyglutamate levels using pharmacogenetics

Details for Australian Patent Application No. 2005257949 (hide)

Owner Prometheus Laboratories, Inc.

Inventors Dervieux, Thierry

Agent Watermark

Pub. Number AU-B-2005257949

PCT Pub. Number WO2006/002049

Priority 11/152,128 13.06.05 US; 60/580,141 15.06.04 US

Filing date 14 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 16 September 2010

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/002049 Priority application(s): WO2006/002049

16 September 2010 Application Accepted

  Published as AU-B-2005257949

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005257952-Method of improving animal tissue quality by supplementing the animal diet with oleic acid and selected tocols

2005257938-Immunostimulatory oligonucleotide multimers